Vanda Pharmaceuticals EV 2011-2026 | VNDA

EV Jährlich Vanda Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
435 M	276 M	200 M	384 M	908 M	734 M	719 M	1.43 B	765 M	616 M	390 M	337 M	431 M	159 M	200 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
1.43 B	159 M	532 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	1.22 B	$ 3.56	-	$ 1.06 B	Canada
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	82.4 M	$ 3.13	-	$ 229 M	Schweiz
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	6.28 M	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	33.1 M	-	10.36 %	$ 9.8 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
ADC Therapeutics SA ADCT	114 M	$ 4.22	-	$ 105 M	Schweiz
Aptorum Group Limited APM	9.45 M	$ 0.79	0.01 %	$ 4.31 M	China
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
argenx SE ARGX	-796 M	$ 703.3	-	$ 25 B	Niderland
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Ascendis Pharma A/S ASND	849 M	$ 231.03	2.23 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.61	-	$ 8.69 B	Australia
Atea Pharmaceuticals AVIR	370 M	$ 6.05	-	$ 493 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
Arcturus Therapeutics Holdings ARCT	43.4 M	$ 6.63	-	$ 182 M	Israel
BioCardia BCDA	12.4 M	$ 1.27	-	$ 26.9 M	USA
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
Athersys ATHX	-37.4 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	-14.1 M	-	3.16 %	$ 1.9 M	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AlloVir ALVR	-64.1 M	-	4.14 %	$ 49.1 M	USA
Catalyst Biosciences CBIO	986 M	$ 11.58	-	$ 1.03 B	USA
Cerus Corporation CERS	632 M	$ 1.8	6.51 %	$ 343 M	USA
Anika Therapeutics ANIK	300 M	$ 14.36	-	$ 210 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
BioNTech SE BNTX	-4.91 B	$ 90.54	-	$ 27.2 B	Germany
Aptose Biosciences APTO	10.8 M	-	-45.71 %	$ 1.2 M	Canada
Burford Capital Limited BUR	3.22 B	$ 8.05	-	$ 1.34 B	Britain
AVEO Pharmaceuticals AVEO	86.9 M	-	-	$ 521 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
CNS Pharmaceuticals CNSP	-3.42 M	$ 2.45	0.41 %	$ 936 K	USA
Aytu BioScience AYTU	-15.2 M	$ 2.64	-	$ 16.6 M	USA
Cardiff Oncology CRDF	115 M	$ 1.9	-	$ 127 M	USA
CorMedix CRMD	276 M	$ 6.54	-	$ 471 K	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	1.11 B	$ 1.51	-	$ 385 M	Britain